Article: | MedLuna.com

Overview

Journal Clin Liver Dis (Hoboken)

Specialty Gastroenterology

Date 2019 Jul 24

PMID 31333827

Authors

Andres F Carrion

Paul Martin

Affiliations

Soon will be listed here.

References

Gursoy M, Guvener N, Koksal R, Karavelioglu D, Baysal C, Ozdemir N . Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients. Transplant Proc. 2000; 32(3):561-2. DOI: 10.1016/s0041-1345(00)00890-3. View

Tan A, Brouwer J, Glue P, van Leusen R, Kauffmann R, Schalm S . Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study. Nephrol Dial Transplant. 2001; 16(1):193-5. DOI: 10.1093/ndt/16.1.193. View

Bruchfeld A, Stahle L, Andersson J, Schvarcz R . Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study. J Viral Hepat. 2001; 8(4):287-92. DOI: 10.1046/j.1365-2893.2001.00300.x. View

Lee W, Shu K, Cheng C, Wu M, Chen C, Lian J . Long-term impact of hepatitis B, C virus infection on renal transplantation. Am J Nephrol. 2001; 21(4):300-6. DOI: 10.1159/000046265. View

Fabrizi F, Poordad F, Martin P . Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002; 36(1):3-10. DOI: 10.1053/jhep.2002.34613. View

Morales J . Hepatitis C virus infection and renal disease after renal transplantation. Transplant Proc. 2004; 36(3):760-2. DOI: 10.1016/j.transproceed.2004.03.041. View

Mousa D, Abdalla A, Al-Shoail G, Al-Sulaiman M, Al-Hawas F, Al-Khader A . Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Transplant Proc. 2004; 36(6):1831-4. DOI: 10.1016/j.transproceed.2004.07.025. View

Bruchfeld A, Wilczek H, Elinder C . Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation. Transplantation. 2004; 78(5):745-50. DOI: 10.1097/01.tp.0000131948.29742.24. View

Konishi I, Horiike N, Michitaka K, Ochi N, Furukawa S, Minami H . Renal transplant recipient with chronic hepatitis C who obtained sustained viral response after interferon-beta therapy. Intern Med. 2004; 43(10):931-4. DOI: 10.2169/internalmedicine.43.931. View

10.

Dixit N, Layden-Almer J, Layden T, Perelson A . Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature. 2004; 432(7019):922-4. DOI: 10.1038/nature03153. View

11.

Finelli L, Miller J, Tokars J, Alter M, Arduino M . National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial. 2005; 18(1):52-61. DOI: 10.1111/j.1525-139X.2005.18108.x. View

12.

Mahmoud I, Sobh M, El-Habashi A, Sally S, El-Baz M, El-Sawy E . Interferon therapy in hemodialysis patients with chronic hepatitis C: study of tolerance, efficacy and post-transplantation course. Nephron Clin Pract. 2005; 100(4):c133-9. DOI: 10.1159/000085442. View

13.

Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G . Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005; 5(6):1452-61. DOI: 10.1111/j.1600-6143.2005.00864.x. View

14.

Kalantar-Zadeh K, McAllister C, Miller L . Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study. Nephrol Dial Transplant. 2005; 20(8):1662-9. DOI: 10.1093/ndt/gfh895. View

15.

Izopet J, Sandres-Saune K, Kamar N, Salama G, Dubois M, Pasquier C . Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol. 2005; 77(1):70-6. DOI: 10.1002/jmv.20415. View

16.

Ozdemir B, Ozdemir F, Sezer S, Colak T, Haberal M . De novo glomerulonephritis in renal allografts with hepatitis C virus infection. Transplant Proc. 2006; 38(2):492-5. DOI: 10.1016/j.transproceed.2005.12.109. View

17.

Armstrong G, Wasley A, Simard E, McQuillan G, Kuhnert W, Alter M . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006; 144(10):705-14. DOI: 10.7326/0003-4819-144-10-200605160-00004. View

18.

Chan T, Lok A, Cheng I . Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1991; 6(12):944-7. DOI: 10.1093/ndt/6.12.944. View

19.

Rendina M, Schena A, Castellaneta N, Losito F, Amoruso A, Stallone G . The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant. J Hepatol. 2007; 46(5):768-74. DOI: 10.1016/j.jhep.2006.12.016. View

20.

Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, MARTIN P . The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007; 14(10):697-703. DOI: 10.1111/j.1365-2893.2007.00868.x. View